Blue Jet Healthcare Limited
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance… Read more
Blue Jet Healthcare Limited (BLUEJET) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2023: 0.060x
Based on the latest financial reports, Blue Jet Healthcare Limited (BLUEJET) has a cash flow conversion efficiency ratio of 0.060x as of September 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹460.32 Million) by net assets (₹7.74 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Blue Jet Healthcare Limited - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Blue Jet Healthcare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Blue Jet Healthcare Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Blue Jet Healthcare Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lucky Strike Entertainment Corporation
NYSE:LUCK
|
0.074x |
|
Quoc Cuong Gia Lai JSC
VN:QCG
|
0.004x |
|
NOCIL Limited
NSE:NOCIL
|
0.077x |
|
Nordfyns Bank A/S
CO:NRDF
|
0.003x |
|
Vinte Viviendas Integrales S.A.B. de C.V
MX:VINTE
|
-0.033x |
|
Daiken Biomedical Co., Ltd.
TW:7780
|
0.006x |
|
Easy Trip Planners Limited
NSE:EASEMYTRIP
|
0.008x |
|
Acme United Corporation
NYSE MKT:ACU
|
0.061x |
Annual Cash Flow Conversion Efficiency for Blue Jet Healthcare Limited (2020–2025)
The table below shows the annual cash flow conversion efficiency of Blue Jet Healthcare Limited from 2020 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹11.33 Billion | ₹457.65 Million | 0.040x | -85.85% |
| 2024-03-31 | ₹8.45 Billion | ₹2.41 Billion | 0.285x | +37.42% |
| 2023-03-31 | ₹6.81 Billion | ₹1.42 Billion | 0.208x | -26.01% |
| 2022-03-31 | ₹5.22 Billion | ₹1.46 Billion | 0.281x | -26.57% |
| 2021-03-31 | ₹3.40 Billion | ₹1.30 Billion | 0.382x | -36.84% |
| 2020-03-31 | ₹2.03 Billion | ₹1.23 Billion | 0.605x | -- |